David N Cook

This inventor holds 21 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 3 EPO patents, primarily in Pathogen Inactivation. Top assignees: Cerus Corporation, Aduro Biotech Inc., Anza Therapeutics, Inc.. Active years: 1996-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David N Cook. Retrieved from https://idiyas.com/inventor/david-n-cook-oaola3mi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21 (Patent Applications = 3)

% Patents Active = 66.7

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 3 (Patent Applications = 1)

Average Co-Inventor Count = 3.2

ph-index = 16

Forward Citations = 496(Granted Patents)

Location History:

Walnut Creek, CA (US) (1996 - 2002)
Lexington, MA (US) (2003 - 2004)
Lafayette, CA (US) (2000 - 2017)

Company Filing History:

Anza Therapeutics, Inc.

patent

4. 1 out of 65

Miltenyi Biotec, Gmbh

Years Active: 1996-2017

Loading Chart...

Areas of Expertise:

Pathogen Inactivation

Engineered Listeria

Modified Microbes

Vaccine Compositions

Nucleic Acid Molecules

Biological Materials

High Density Microparticles

Frangible Compounds

Blood Treatments

Antiviral Agents

Mustard Compounds

Quenching Inactivators

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9764013 - [object Object] (2017-09-19),

2. 8580939 - Engineered Listeria and methods of use thereof (2013-11-12),

3. 8287883 - [object Object] (2012-10-16),

4. 7935804 - [object Object] (2011-05-03),

5. 7927606 - Modified free-living microbes, vaccine compositions and methods of use thereof (2011-04-19),

6. 7842289 - Recombinant nucleic acid molecules, expression cassettes, and bacteria, and methods of use thereof (2010-11-30),

7. 7833775 - Modified free-living microbes, vaccine compositions and methods of use thereof (2010-11-16),

8. 7695725 - Modified free-living microbes, vaccine compositions and methods of use thereof (2010-04-13),

9. 7691393 - [object Object] (2010-04-06),

10. 7293985 - Methods for quenching pathogen inactivators in biological materials (2007-11-13),

11. 6730230 - Use of high density microparticles for removal of pathogens (2004-05-04),

12. 6709810 - Methods for quenching pathogen inactivators in biological materials (2004-03-23),

13. 6514987 - Frangible compounds for pathogen inactivation (2003-02-04),

14. 6410219 - Treating blood or blood products with compounds which have a mustard, azirdinium or aziridine group and a nucleic acid binding group (2002-06-25),

15. 6270952 - Methods for quenching pathogen inactivators in biological materials (2001-08-07),

Title: David N Cook - Innovator in Biotechnology

Introduction

David N Cook is a prolific inventor based in Lafayette, California. With an impressive portfolio of 21 patents to his name, Cook has made significant contributions to the field of biotechnology, particularly in the development of engineered bacteria for medical applications.

Latest Patents

Among David N Cook's latest inventions is a novel bacterium containing a polynucleotide comprising a nucleic acid encoding a heterologous antigen, along with fusion protein partners. This invention also introduces vectors for mediating site-specific recombination and vectors that include removable antibiotic resistance genes. Additionally, his work on engineered Listeria showcases the potential of modified bacteria in therapeutic settings.

Career Highlights

Throughout his career, David has worked at leading biotechnology companies, including Cerus Corporation and Aduro Biotech Inc. His innovative research has paved the way for advancements in medical treatments and vaccine development, positioning him as a key player in the biotech industry.

Collaborations

Cook has collaborated with noted professionals in the field, such as Thomas W Dubensky, Jr. and Susan Wollowitz. These partnerships have fostered a collaborative environment that enhances research and development efforts, leading to groundbreaking innovations.

Conclusion

David N Cook's contributions to biotechnology through his various patents demonstrate his creative approach and commitment to advancing medical science. His work continues to inspire future innovations in the field, highlighting the importance of intellectual property in driving progress in research and development.

Profile summary based on public USPTO records.